Framatome To Supply Fuel To VVER Reactors In Slovakia Framatome (ENS Corporate Member) and Slovak utility Slovenské elektrárne have signed a major contract for the long-term supply of nuclear fuel to the Bohunice and Mochovce VVER reactors from 2027. This contract marks a new milestone in the longstanding and fruitful cooperation between Framatome and Slovenské…
Framatome To Support Czech Nuclear Fuel Diversification Framatome (ENS Corporate Member) and Czech utility ČEZ have signed a Memorandum of Understanding (MoU) relating to Framatome’s own-design VVER-1000 fuel development programme. We are pleased to take another step in the development of a Framatome own-design VVER-1000 fuel design, with a view to ensuring the safe, reliable and…
Framatome Advances Towards Producing Lu-177 In Romania Framatome (ENS Corporate Member) and Nuclearelectrica have announced the successful outcome of the feasibility study which assessed the possibility of producing medical isotope Lutetium-177 (Lu-177) at the Cernavoda nuclear power plant in Romania. The two companies have now launched the implementation of the project, covering detailed engineering, procurement,…
Framatome Will Supply Fuel to Hungary’s VVER Reactors On 25 October, Framatome and MVM Paks Nuclear Power Plant Ltd. (ENS Corporate Members) announced the signing of a major contract for the long-term supply of nuclear fuel to the Hungarian Paks VVER reactors from 2027. The contract ensuring the fuel supply diversification of Hungary is based…
Framatome To Study Medical Radioisotopes Production At Argentinian NPPs Framatome (ENS Corporate Member) and Nucleoeléctrica Argentina have signed an agreement to conduct a pre-feasibility study on installing systems for producing short-lived radioisotopes, such as Lutetium-177, at the nuclear power plants operated by the Argentine company: Atucha I, Atucha II, and Embalse. The study is expected…
Framatome and IBA To Partner To Advance Scale-Production Of Astatine-211 Framatome (ENS Corporate Member) and IBA (Ion Beam Applications S.A., EURONEXT) announced the signature of a Memorandum Of Understanding to start a strategic partnership aimed at advancing industrial-scale production of Astatine-211 (211At), an alpha-emitting radioisotope across Europe and the United States. 211At is a highly…
Framatome and Perpetual Atomics to Advance Industrialisation of Space Batteries for Space Exploration Framatome (ENS Corporate Member) and Perpetual Atomics have signed a Memorandum of Understanding (MoU) to study the industrialisation of processing americium into sealed sources for radioisotope power systems (“space batteries”), including radioisotope heater units (RHUs) and radioisotope thermoelectric generators (RTGs). A radioisotope…
Framatome Opened a New Fuel Fabrication Facility for Research Reactors and Medical Applications Earlier this month, Framatome (ENS Corporate Member) inaugurated a new CERCA workshop in Romans-sur-Isère (France). The new facility, opened on 18th April, is dedicated to the fabrication of fuel for research reactors and targets for medical isotopes. The Framatome site in Romans-sur-Isère includes the CERCA…
Framatome and Leibstadt NPP Signed A Long-Term Fuel Supply Contract Framatome and Kernkraftwerk Leibstadt AG (KKL – both ENS Corporate Members) have signed a long-term contract to supply ATRIUM 11 fuel assemblies to its Swiss nuclear power plant over the period 2028-2035. Framatome has been supplying KKL since 2008, providing ATRIUM 11 – a fuel…
Framatome to Support LTO of the Belgian Nuclear Fleet Electrabel has selected Framatome (ENS Corporate Member) for two major projects: the modernization of the Flux Monitoring System (FMS) of the Tihange 3 reactor, and the modernization, maintenance, and operational support of the motors and stators of the Reactor Coolant Pumps (RCP) at Doel 4 and Tihange…